IMMUNOVANT, INC. Authorized Dilution
Share-issuance capacity and approved equity plans, with the disclosed share class, period, approval and expiry. Gross charter headroom is authorized minus issued shares, not a forecast. Equity plan reserves may use weighted counting rules, overlap charter capacity, and must not be added to it. Outstanding awards, future grants, and proposed approvals are distinct. * denotes calculated capacity.
| As of | Authorization / plan | Share class | Authorized / approved limit (shares) | Issued shares / outstanding awards (shares) | Remaining capacity (shares / reserve units) | Approval status | Approval date | Expiry / conditions | Basis / limitations | Source |
|---|